Influencing Factors and Predictive Model for Left Atrial Appendage Emptying Velocity in Nonvalvular AF Patients

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2024 Oct 4

PMID 39364064

Authors

Weibin He

Lei Yin

Qian Liu

Yan Zhang

Yanlei Zhao

Lianxia Wang

Ling You

Affiliations

Soon will be listed here.

Abstract

Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia, significantly increasing the risk of death and stroke. The left atrial appendage (LAA) plays a crucial role in the development of AF. Reduced left atrial appendage emptying velocity (LAAEV) is an important indicator of nonvalvular AF, associated with thrombosis and recurrence after catheter ablation. This study aims to identify factors influencing LAAEV and construct a predictive model for LAAEV in nonvalvular AF patients.

Methods: This retrospective cohort study included 1,048 nonvalvular AF patients hospitalized at the Second Hospital of Hebei Medical University from January 1, 2015, to December 31, 2021. Patients underwent transthoracic and transesophageal echocardiography and had complete laboratory data. Statistical analyses included binary logistic regression and multiple linear regression to identify independent predictors of reduced LAAEV and construct a predictive model.

Results: Patients were divided into two groups: reduced LAAEV (<40 cm/s) and normal LAAEV (≥40 cm/s). The reduced LAAEV group included 457 patients (43.61%), with significant differences in age, gender, alcohol consumption, heart failure (HF), ischemic stroke, AF type, resting heart rate, CHA2DS2-VASc score, serum creatinine (SCR), serum uric acid (SUA), estimated glomerular filtration rate (eGFR), glycated hemoglobin (HbA1C), β2 macroglobulin (B2M), left atrial diameter (LAD), and left ventricular ejection fraction (LVEF) compared to the normal LAAEV group. Logistic regression analysis identified age (OR 0.974, 95% CI 0.951-0.997, = 0.028), HF (OR 0.637, 95% CI 0.427-0.949, = 0.027), AF type [Persistent AF vs. PAF (OR 0.063, 95% CI 0.041-0.095, = 0) Long-standing Persistent AF vs. PAF (OR 0.077, 95% CI 0.043-0.139, = 0)], LAD (OR 0.872, 95% CI 0.836-0.91, < 0.001), and LVEF (OR 1.057, 95% CI 1.027-1.089, = 0) as independent predictors of reduced LAAEV. Multiple linear regression analysis included age, AF type, LAD, and LVEF in the final predictive model, explaining 43.5% of the variance in LAAEV (adjusted R² = 0.435).

Conclusion: Age, HF, type of AF, LAD, and LVEF are independent predictors of reduced LAAEV. The predictive model (LAAEV = 96.567-15.940 × AFtype-1.309 × LAD-0.18 × Age + 37.069 × LVEF) demonstrates good predictive value, aiding in the initial assessment and management of nonvalvular AF patients.

References

Kiedrowicz R, Wielusinski M, Wojtarowicz A, Kazmierczak J . Left and right atrial appendage functional features as predictors for voltage-defined left atrial remodelling in patients with long-standing persistent atrial fibrillation. Heart Vessels. 2021; 36(6):853-862. PMC: 8093174. DOI: 10.1007/s00380-020-01752-4. View

Singh A, Singulane C, Miyoshi T, Prado A, Addetia K, Bellino M . Normal Values of Left Atrial Size and Function and the Impact of Age: Results of the World Alliance Societies of Echocardiography Study. J Am Soc Echocardiogr. 2021; 35(2):154-164.e3. DOI: 10.1016/j.echo.2021.08.008. View

Benjamin E, Wolf P, DAgostino R, Silbershatz H, Kannel W, Levy D . Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998; 98(10):946-52. DOI: 10.1161/01.cir.98.10.946. View

Hagii J, Metoki N, Saito S, Shiroto H, Sasaki S, Takahashi K . Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation. Thromb J. 2021; 19(1):22. PMC: 8011096. DOI: 10.1186/s12959-021-00276-9. View

Hori Y, Nakahara S, Nishiyama N, Fukuda R, Ukaji T, Sato H . Impact of low-voltage zones on the left atrial anterior wall on the reduction in the left atrial appendage flow velocity in persistent atrial fibrillation patients. J Interv Card Electrophysiol. 2019; 56(3):299-306. DOI: 10.1007/s10840-019-00532-z. View

Shah M, Mobaligh N, Niku A, Shiota T, Siegel R, Rader F . Predictors of left atrial appendage thrombus despite NOAC use in nonvalvular atrial fibrillation and flutter. Int J Cardiol. 2020; 317:86-90. DOI: 10.1016/j.ijcard.2020.04.070. View

Hanif W, Alex L, Su Y, Shinde A, Russo I, Li N . Left atrial remodeling, hypertrophy, and fibrosis in mouse models of heart failure. Cardiovasc Pathol. 2017; 30:27-37. PMC: 5592139. DOI: 10.1016/j.carpath.2017.06.003. View

Ma N, Lu R, Zhao D, Jiang Z, Tang M, Bao C . Left Atrial Appendage Fibrosis and 3-Year Clinical Outcomes in Atrial Fibrillation After Endoscopic Ablation: A Histologic Analysis. Ann Thorac Surg. 2019; 109(1):69-76. DOI: 10.1016/j.athoracsur.2019.05.055. View

Yang S, Zhang Y, Chen N, Shi J, Ju W, Chen H . Characteristics, Thrombus Resolution, and Long-Term Outcomes in Patients with Nonvalvular Atrial Fibrillation and Atrial Thrombus. Clin Appl Thromb Hemost. 2023; 29:10760296231168097. PMC: 10126607. DOI: 10.1177/10760296231168097. View

10.

Jin X, Nauta J, Hung C, Ouwerkerk W, Teng T, Voors A . Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis. Heart Fail Rev. 2022; 27(5):1933-1955. PMC: 9388424. DOI: 10.1007/s10741-021-10204-8. View

11.

Zhang W, Xiong Y, Yu L, Xiong A, Bao H, Cheng X . Meta-analysis of Stroke and Bleeding Risk in Patients with Various Atrial Fibrillation Patterns Receiving Oral Anticoagulants. Am J Cardiol. 2019; 123(6):922-928. DOI: 10.1016/j.amjcard.2018.11.055. View

12.

Da Costa A, Delolme C, Guichard J, Gerbay A, Pierrard R, Romeyer-Bouchard C . Comparison of prevalence and management of left atrial appendage thrombi under old and new anticoagulants prior to left atrial catheter ablation. Am Heart J. 2017; 193:8-15. DOI: 10.1016/j.ahj.2017.07.016. View

13.

Xue J, Lin Y, Huang W, Chen X, Li Q, Cai Z . Left atrial size and risk of recurrent ischemic stroke in a Chinese population. Brain Behav. 2017; 7(5):e00702. PMC: 5434199. DOI: 10.1002/brb3.702. View

14.

Morillo C, Verma A, Connolly S, Kuck K, Nair G, Champagne J . Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014; 311(7):692-700. DOI: 10.1001/jama.2014.467. View

15.

Zabalgoitia M, Halperin J, Pearce L, Blackshear J, Asinger R, Hart R . Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol. 1998; 31(7):1622-6. DOI: 10.1016/s0735-1097(98)00146-6. View

16.

Pollick C, Taylor D . Assessment of left atrial appendage function by transesophageal echocardiography. Implications for the development of thrombus. Circulation. 1991; 84(1):223-31. DOI: 10.1161/01.cir.84.1.223. View

17.

Wolf P, Kannel W, McGee D, Meeks S, Bharucha N, MCNAMARA P . Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke. 1983; 14(5):664-7. DOI: 10.1161/01.str.14.5.664. View

18.

Obel O, Camm A . Left atrial appendage: structure, function, and role in thromboembolism. Heart. 1999; 82(5):547-54. PMC: 1760793. DOI: 10.1136/hrt.82.5.547. View

19.

Tabata T, Oki T, Fukuda N, Iuchi A, Manabe K, Kageji Y . Influence of aging on left atrial appendage flow velocity patterns in normal subjects. J Am Soc Echocardiogr. 1996; 9(3):274-80. DOI: 10.1016/s0894-7317(96)90140-6. View

20.

Celik M, Yalcinkaya E, Yuksel U, Gokoglan Y, Bugan B, Kabul H . Increased serum uric acid levels are correlated with decreased left atrial appendage peak flow velocity in patients with atrial fibrillation. Med Princ Pract. 2015; 24(3):263-8. PMC: 5588229. DOI: 10.1159/000373892. View